title: Use of enhanced counterpulsation in the treatment of refractory angina pectoris and congestive heart failure.
abstract: Enhanced external counterpulsation (EECP) is a Food and Drug Administration approved non-pharmacological treatment for angina pectoris refractory to medical management and for use in the treatment of congestive heart failure. EECP improves quality of life, symptoms and exercise duration in these patients.
authors.affiliation: Department of Medicine, Sound Shore Medical Center of Westchester, New York Medical College, New Rochelle, New York, USA.
authors.forename: Anil
authors.initials: A
authors.lastname: Kumar
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
mesh_terms: D000787:Angina Pectoris / Q000628:therapy*; D015908:Counterpulsation / Q000009:adverse effects / Q000379:methods*; D017079:Exercise Tolerance; D006333:Heart Failure / Q000628:therapy*; D006801:Humans